Thyroid cancer is the most common endocrine cancer, affecting more people each year as detection rates continue to rise.
Detecting cancer in the earliest stages could dramatically reduce cancer deaths because cancers are usually easier to treat when caught early.
A blood-based colorectal cancer (CRC) screening test, SimpleScreen™, has shown a significant leap in performance, ...
Cancer is the second leading cause of death worldwide. Since age is one of the risk factors for the development of cancer, ...
Thyroid cancer is the most common endocrine cancer, affecting more people each year as detection rates continue to rise.
Galleri is a blood test that aims to detect over 50 types of cancer early. It analyzes cell-free DNA (cfDNA) and methylation patterns to identify potential cancer signals. The test is intended for ...
Using a single blood sample, multi-cancer early detection (MCED) tests screen for numerous types of cancers, including breast, ovarian, colorectal, pancreatic and prostate cancers. Trials are underway ...